Document is current
Any future updates will be listed below
-
Authors
Koroki, Yosuke https://orcid.org/0000-0003-1461-5869
Taguri, Masataka https://orcid.org/0000-0001-8902-0056
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01715285 at ClinicalTrials.govDocuments that mention this clinical trial
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study
https://doi.org/10.1016/j.ejca.2015.03.021
Clinical Outcomes of First Subsequent Therapies After Abiraterone Acetate Plus Prednisone for High-Risk Metastatic Castration-Sensitive Prostate Cancer in the LATITUDE Study
https://doi.org/10.1007/s11523-022-00929-3
-
Funding
Funding for this research was provided by:
Janssen Pharmaceutical K.K.
- License Information
-
More Information
Article History
Accepted: 28 October 2022
First Online: 28 November 2022
Declarations
:
: The LATITUDE study was funded by Janssen Research & Development. Editorial support of this study was funded by Janssen Pharmaceutical K.K.
: YK is an employee of Janssen Pharmaceutical K.K. and holds stock in Johnson & Johnson. MT has nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the local institutional review boards for each site and conformed with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent, including permission for patient data to be used in post hoc analyses such as the present study, was obtained from all individual participants included in the LATITUDE study (ClinicalTrials.gov, NCT01715285).
: Patients signed informed consent regarding publishing their data.
: The code used during the current study is available from the corresponding author on reasonable request.
: The data sharing policy of the study sponsor, Janssen Pharmaceutical Companies of Johnson & Johnson, is available online. Requests for access to the study data can be submitted through the Yale Open Data Access Project site. For Janssen’s data sharing policy, see . For the Yale Open Data Access Project, see .
: YK and MT contributed to the study’s conception and design. Material preparation and analysis were performed by YK. The first draft of the manuscript was written by YK, and all authors commented on previous versions of the manuscript. All authors have read and approved the final manuscript.
